Adalimumab impact on fatigue measured by FACIT-F: a study of rheumatoid arthritis patients in Saudi Arabia

Código QR

Adalimumab impact on fatigue measured by FACIT-F: a study of rheumatoid arthritis patients in Saudi Arabia

Nahed Janoudi,1 Narges Omran,2 Waleed Hussain,3 Hanan Al-osaimi,4 Matouqa Baamer,5 Muhammad Irfanullah Siddiqui,6 Omar Fathaldin,7 Hani Almoallim1,4,8 1Department of Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, 2Department of Medicine, Alnoor General Hospital, 3Department of Medicine, Heraa Genera...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Janoudi N, Omran N, Hussain W, Al-osaimi H, Baamer M, Siddiqui MI, Fathaldin O, Almoallim H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	rheumatoid arthritis fatigue adalimumab disease activity Diseases of the musculoskeletal system RC925-935
Acceso en línea:	https://doaj.org/article/03993431cd0c47c8950cb96013a3323d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A rare case of suicidal ideation related to Adalimumab use
por: Jafri F, et al.
Publicado: (2018)

Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability – Saudi Rheumatoid Arthritis Registry
por: Almoallim H, et al.
Publicado: (2019)

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
por: Alvisi P, et al.
Publicado: (2019)

Adverse Impact of Rheumatoid Arthritis on Pregnancy Outcomes: A Saudi Arabia Prospective Multicenter Study
por: Al Rayes H, et al.
Publicado: (2021)

Rheumatoid Arthritis Saudi Database (RASD): Disease Characteristics and Remission Rates in a Tertiary Care Center
por: Almoallim H, et al.
Publicado: (2020)

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Aline Lissa Okita, et al.
Publicado: (2020)

A Rare Infectious Complication of a Treatment with Biologics: Disseminated Cutaneous Leishmaniasis Associated with Adalimumab
por: Kerasia-Maria Plachouri, et al.
Publicado: (2020)

Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
por: Madani A, et al.
Publicado: (2021)

Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study
por: AlOmair M, et al.
Publicado: (2021)

A Comparison of Demographics, Disease Activity, Disability, and Treatment Among Rheumatoid Arthritis Patients with and without Osteoporosis
por: Abdulkhaliq A, et al.
Publicado: (2021)

Delanzomib, a Novel Proteasome Inhibitor, Combined With Adalimumab Drastically Ameliorates Collagen-Induced Arthritis in Rats by Improving and Prolonging the Anti-TNF-α Effect of Adalimumab
por: Lei Wang, et al.
Publicado: (2021)

Fetal Acrania (Exencephaly) in the Context of a Pregnant Female Taking Adalimumab for Psoriasis: A Case Report
por: Daham N, et al.
Publicado: (2020)

Clinical profile and comorbidities associated with rheumatoid arthritis patients in Sudair, Saudi Arabia
por: Fehaid Alanazi
Publicado: (2021)

Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
por: Sook Yan Lee, et al.
Publicado: (2021)

ANCA-Associated Vasculitis Clinical Presentation and Clinical Predictors of Relapse in Saudi Arabia
por: Alahmari H, et al.
Publicado: (2021)

Efficacy And Safety Of Adalimumab Biosimilar (Exemptia) In Moderate-To-Severe Steroid-Refractory Ulcerative Colitis Patients: Real-Life Outcomes In Resource-Constrained Setting At 24-Weeks Follow-Up
por: Chandra A, et al.
Publicado: (2019)

Determining early referral criteria for patients with suspected inflammatory arthritis presenting to primary care physicians: a cross-sectional study
por: Almoallim H, et al.
Publicado: (2017)

The journey of rheumatoid arthritis patients: a review of reported lag times from the onset of symptoms
por: Barhamain AS, et al.
Publicado: (2017)

Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca G, et al.
Publicado: (2013)

A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
por: Byron P. Vaughn
Publicado: (2021)

Fatigue in Saudi Patients with Primary Sjögren’s Syndrome and Its Correlation with Disease Characteristics and Outcome Measures: A Cross-Sectional Study
por: AlEnzi F, et al.
Publicado: (2020)

The onset of rheumatoid arthritis following trauma
por: Brawer AE, et al.
Publicado: (2016)

International journal of fatigue
Publicado: (1979)

Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved
por: Luis G. Guijarro, et al.
Publicado: (2021)

Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
por: Ríos C, et al.
Publicado: (2017)

Physical and Emotional Burden of Rheumatoid Arthritis in Saudi Arabia: An Exploratory Cross-Sectional Study
por: Omair MA, et al.
Publicado: (2020)

AUTOANTIBODIES TO CIRTULLINATED ANTIGENS FOR DIAGNOSIS AND PREDICTION OF CLINICAL COURSE IN EARLY RHEUMATOID ARTHRITIS
por: I. B. Belyaeva, et al.
Publicado: (2014)

Chronic fatigue syndrome
por: Moss-Morris, Rona, 1962-
Publicado: (2000)

Clinical utility of anti-carbamylated antibody in rheumatoid arthritis female patients: Emerging predictive value compared to anti-cyclic citrullinated peptide and rheumatoid factor
por: Ahmed E. Hafez, et al.
Publicado: (2022)

Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action
por: Gillis T, et al.
Publicado: (2017)

Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
por: Almalag H, et al.
Publicado: (2020)

Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database
por: Tuhin Maity, et al.
Publicado: (2021)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
por: Ulusoy H, et al.
Publicado: (2020)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
por: Mysler E, et al.
Publicado: (2021)

PSYCHOPHYSIOLOGICAL AND IMMUNE STATUS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: T. Y. Abramova, et al.
Publicado: (2014)

Rheumatoid Arthritis Onset from Shoulder Monoarthritis
por: Ishida K, et al.
Publicado: (2021)

СLINICAL EFFICIENCY OF STATINS IN RHEUMATOID ARTHRITIS: A PILOT STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
por: Bogdan Batko, et al.
Publicado: (2018)

EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

RHEUMATOID ARTHRITIS: LABORATORY MODELS OF THE DISEASE
por: I. A. Orlovskaya, et al.
Publicado: (2015)